BiotechTube
Home/BioFactura/Darryl Sampey, Ph.D.
DS

Darryl Sampey, Ph.D.

President and Chief Executive Officer

BioFactura

Therapeutic Areas

Autoimmune DiseasesInfectious DiseasesOncologyBiodefense

BioFactura Pipeline

DrugIndicationPhase
BFI-751 (ustekinumab biosimilar)Autoimmune Diseases (e.g., psoriasis, Crohn's)Phase 1
Smallpox TherapeuticSmallpox infection (Biodefense)Pre-clinical/Development
Ebola TherapeuticEbola virus infection (Biodefense)Pre-clinical/Development
Novel Cancer Drug(s)CancerPre-clinical

Leadership Team at BioFactura

JN
Jeffrey N. Hausfeld, M.D., M.B.A., F.A.C.S.
Chairman and Chief Medical Officer
View full BioFactura profile